Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Gains from Investment Securities (2018 - 2026)

TransMedics has reported Gains from Investment Securities over the past 8 years, most recently at -$657000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 146.96% year-over-year to -$657000.0; the TTM value through Dec 2025 reached $44.5 million, down 1.46%, while the annual FY2025 figure was $2.6 million, 6.46% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$657000.0 at TransMedics, down from $407863.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $28.8 million in Q4 2023 and troughed at -$657000.0 in Q4 2025.
  • A 5-year average of $2.8 million and a median of $407863.0 in 2025 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 409.82% in 2022 and later plummeted 146.96% in 2025.
  • Year by year, Gains from Investment Securities stood at $160800.0 in 2021, then surged by 9161.82% to $14.9 million in 2022, then skyrocketed by 93.57% to $28.8 million in 2023, then tumbled by 95.15% to $1.4 million in 2024, then plummeted by 146.96% to -$657000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for TMDX at -$657000.0 in Q4 2025, $407863.0 in Q3 2025, and $296672.0 in Q2 2025.